Linagliptin Indications Diajenta is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults. Pharmacology Linagliptin is indicated to improve glycemic control in patients with type 2 diabetes mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4), an enzyme that degrades the incretin hormones GLP-1 (glucagon like peptide-1) and GIP […]
Linagliptin INN & Metformin Hcl BP DIABETES » DPP-4 INHIBITORS & BIGUANIDE INDICATION Lino-M tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. DOSAGE AND ADMINISTRATION Age and Body Weight:Adult, age over 18 years. Dosage […]
Linagliptin DIABETES » DPP-4 INHIBITORS INDICATION Linagliptin is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults. As Monotherapy: In patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment. As combination therapy: in combination with […]
Generic Name: LinagliptinDosage Form: TabletTG Name: Endocrine & Diabetes What is Traneta®?Traneta® is a preparation of Linagliptin 5 mg tablet, used for the treatment of Type-2 diabetes. It is a unique DPP-4 inhibitor which acts non-renal excretion pathway. As a result no dose adjustment is required and no regular kidney screening is required for dose adjustment decision. What are […]
LinagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: The recommended dose of Linita™ is one tablet once daily. No dosage adjustment is required in patients with type 2 diabetes having renal or hepatic impairment Preparation: Linita™ Tablet: Box containing 30 tablets in blister pack.